Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6374082, 14 pages
http://dx.doi.org/10.1155/2016/6374082
Research Article

Multiple Genetic Associations with Irish Wolfhound Dilated Cardiomyopathy

1Faculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, The University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK
2Department of Pharmacology, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA

Received 5 August 2016; Accepted 27 September 2016

Academic Editor: Zhiyong Lei

Copyright © 2016 Siobhan Simpson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Egenvall, B. N. Bonnett, and J. Häggström, “Heart disease as a cause of death in insured Swedish dogs younger than 10 years of age,” Journal of Veterinary Internal Medicine, vol. 20, no. 4, pp. 894–903, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. C. Vollmar, “The prevalence of cardiomyopathy in the Irish wolfhound: a clinical study of 500 dogs,” Journal of the American Animal Hospital Association, vol. 36, no. 2, pp. 125–132, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Mestroni, C. Rocco, D. Gregori et al., “Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity,” Journal of the American College of Cardiology, vol. 34, no. 1, pp. 181–190, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Posafalvi, J. C. Herkert, R. J. Sinke et al., “Clinical utility gene card for: dilated cardiomyopathy (CMD),” European Journal of Human Genetics, vol. 21, no. 10, p. 1185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Distl, A. C. Vollmar, C. Broschk, H. Hamann, and P. R. Fox, “Complex segregation analysis of dilated cardiomyopathy (DCM) in Irish wolfhounds,” Heredity, vol. 99, no. 4, pp. 460–465, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Dambach, A. Lannon, M. M. Sleeper, and J. Buchanan, “Familial dilated cardiomyopathy of young Portuguese water dogs,” Journal of Veterinary Internal Medicine, vol. 13, no. 1, pp. 65–71, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. D. Petric, P. Stabej, and A. Zemva, “Dilated cardiomyopathy in doberman pinschers: survival, causes of death and a pedigree review in a related line,” Journal of Veterinary Cardiology, vol. 4, no. 1, pp. 17–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-B. Mausberg, G. Wess, J. Simak et al., “A locus on chromosome 5 is associated with dilated cardiomyopathy in doberman pinschers,” PLoS ONE, vol. 6, no. 5, Article ID e20042, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. N. G. Mahon, R. T. Murphy, C. A. MacRae, A. L. P. Caforio, P. M. Elliott, and W. J. McKenna, “Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease,” Annals of Internal Medicine, vol. 143, no. 2, pp. 108–115, 2005. View at Google Scholar · View at Scopus
  10. T. W. Lewis, B. Abhayaratne, and S. C. Blott, “Trends in genetic diversity for all Kennel Club registered pedigree dog breeds,” Canine Genetics and Epidemiology, vol. 2, no. 1, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  11. V. J. Adams, K. M. Evans, J. Sampson, and J. L. N. Wood, “Methods and mortality results of a health survey of purebred dogs in the UK,” Journal of Small Animal Practice, vol. 51, no. 10, pp. 512–524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Egenvall, A. Nødtvedt, and H. von Euler, “Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival,” Canadian Journal of Veterinary Research, vol. 71, no. 4, pp. 292–299, 2007. View at Google Scholar · View at Scopus
  13. C. M. Greenwell and P. H. Brain, “Aspiration pneumonia in the Irish wolfhound: a possible breed predisposition,” Journal of Small Animal Practice, vol. 55, no. 10, pp. 515–520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. M. Evans and V. J. Adams, “Mortality and morbidity due to gastric dilatation-volvulus syndrome in pedigree dogs in the UK,” Journal of Small Animal Practice, vol. 51, no. 7, pp. 376–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. E. Mitchell, S. E. Boston, M. Kung et al., “Outcomes of limb-sparing surgery using two generations of metal endoprosthesis in 45 dogs with distal radial osteosarcoma. a veterinary society of surgical oncology retrospective study,” Veterinary Surgery, vol. 45, no. 1, pp. 36–43, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Bhandal and S. E. Boston, “Pathologic fracture in dogs with suspected or confirmed osteosarcoma,” Veterinary Surgery, vol. 40, no. 4, pp. 423–430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Vollmar and P. Fox, “Long-term outcome of irish wolfhound dogs with preclinical cardiomyopathy, atrial fibrillation, or both treated with pimobendan, benazepril hydrochloride, or methyldigoxin monotherapy,” Journal of Veterinary Internal Medicine, vol. 30, no. 2, pp. 553–559, 2016. View at Publisher · View at Google Scholar
  18. C. Clercx, I. Reichler, D. Peeters et al., “Rhinitis/bronchopneumonia syndrome in irish wolfhounds,” Journal of Veterinary Internal Medicine, vol. 17, no. 6, pp. 843–849, 2003. View at Google Scholar · View at Scopus
  19. A. L. Leisewitz, J. A. Spencer, L. S. Jacobson, and H. Schroeder, “Suspected primary immunodeficiency syndrome in three related Irish wolfhounds,” Journal of Small Animal Practice, vol. 38, no. 5, pp. 209–212, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. L. T. Glickman, N. W. Glickman, D. B. Schellenberg, M. Raghavan, and T. L. Lee, “Incidence of and breed-related risk factors for gastric dilatation-volvulus in dogs,” Journal of the American Veterinary Medical Association, vol. 216, no. 1, pp. 40–45, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. K. N. Adamik, I. A. Burgener, A. Kovacevic, S. P. Schulze, and B. Kohn, “Myoglobin as a prognostic indicator for outcome in dogs with gastric dilatation-volvulus,” Journal of Veterinary Emergency and Critical Care, vol. 19, no. 3, pp. 247–253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. B. N. Bonnett, A. Egenvall, Å. Hedhammar, and P. Olson, “Mortality in over 350,000 insured Swedish dogs from 1995–2000: I. Breed-, gender-, age- and cause-specific rates,” Acta Veterinaria Scandinavica, vol. 46, no. 3, pp. 105–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Philipp, A. Vollmar, J. Häggström, A. Thomas, and O. Distl, “Multiple loci are associated with dilated cardiomyopathy in irish wolfhounds,” PLoS ONE, vol. 7, no. 6, Article ID e36691, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. M. Meurs, S. Lahmers, B. W. Keene et al., “A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher,” Human Genetics, vol. 131, no. 8, pp. 1319–1325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Meurs, J. A. Stern, D. D. Sisson et al., “Association of dilated cardiomyopathy with the striatin mutation genotype in boxer dogs,” Journal of Veterinary Internal Medicine, vol. 27, no. 6, pp. 1437–1440, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Werner, M. G. Raducha, U. Prociuk, M. M. Sleeper, T. J. Van Winkle, and P. S. Henthorn, “A novel locus for dilated cardiomyopathy maps to canine chromosome 8,” Genomics, vol. 91, no. 6, pp. 517–521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Lynne O'Sullivan, M. R. O'Grady, W. Glen Pyle, and J. F. Dawson, “Evaluation of 10 genes encoding cardiac proteins in Doberman Pinschers with dilated cardiomyopathy,” American Journal of Veterinary Research, vol. 72, no. 7, pp. 932–938, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. U. Philipp, A. Vollmar, and O. Distl, “Evaluation of six candidate genes for dilated cardiomyopathy in Irish wolfhounds,” Animal Genetics, vol. 39, no. 1, pp. 88–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. C. Wiersma, P. Stabej, P. A. J. Leegwater, B. A. Van Oost, W. E. Ollier, and J. Dukes-McEwan, “Evaluation of 15 candidate genes for dilated cardiomyopathy in the Newfoundland dog,” Journal of Heredity, vol. 99, no. 1, pp. 73–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Lindblad-Toh, C. M. Wade, T. S. Mikkelsen et al., “Genome sequence, comparative analysis and haplotype structure of the domestic dog,” Nature, vol. 438, no. 7069, pp. 803–819, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Simpson, J. Edwards, R. D. Emes, M. A. Cobb, N. P. Mongan, and C. S. Rutland, “A predictive model for canine dilated cardiomyopathy-a meta-analysis of Doberman Pinscher data,” PeerJ, vol. 2015, no. 3, article e842, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. S. E. Brownlie and M. A. Cobb, “Observations on the development of congestive heart failure in Irish wolfhounds with dilated cardiomyopathy,” Journal of Small Animal Practice, vol. 40, no. 8, pp. 371–377, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. M. W. S. Martin, M. J. Stafford Johnson, and B. Celona, “Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases,” Journal of Small Animal Practice, vol. 50, no. 1, pp. 23–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Tidholm and L. Jönsson, “A retrospective study of canine dilated cardiomyopathy (189 cases),” Journal of the American Animal Hospital Association, vol. 33, no. 6, pp. 544–550, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. D. V. Unverferth, R. D. Magorien, M. L. Moeschberger, P. B. Baker, J. K. Fetters, and C. V. Leier, “Factors influencing the one-year mortality of dilated cardiomyopathy,” The American Journal of Cardiology, vol. 54, no. 1, pp. 147–152, 1984. View at Publisher · View at Google Scholar · View at Scopus
  36. C. A. Wasywich, A. J. Pope, J. Somaratne, K. K. Poppe, G. A. Whalley, and R. N. Doughty, “Atrial fibrillation and the risk of death in patients with heart failure: a literature-based meta-analysis,” Internal Medicine Journal, vol. 40, no. 5, pp. 347–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. A. Calvert, C. W. Pickus, G. J. Jacobs, and J. Brown, “Signalment, survival, and prognostic factors in Doberman Pinschers with end-stage cardiomyopathy,” Journal of Veterinary Internal Medicine, vol. 11, no. 6, pp. 323–326, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Wess, A. Schulze, V. Butz et al., “Prevalence of dilated cardiomyopathy in Doberman Pinschers in various age groups,” Journal of Veterinary Internal Medicine, vol. 24, no. 3, pp. 533–538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. U. Philipp, C. Broschk, A. Vollmar, and O. Distl, “Evaluation of tafazzin as candidate for dilated cardiomyopathy in Irish wolfhounds,” Journal of Heredity, vol. 98, no. 5, pp. 506–509, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. N. J. Camp, “Genomewide transmission/disequilibrium testing—consideration of the genotypic relative risks at disease loci,” American Journal of Human Genetics, vol. 61, no. 6, pp. 1424–1430, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. G. M. Clarke, C. A. Anderson, F. H. Pettersson, L. R. Cardon, A. P. Morris, and K. T. Zondervan, “Basic statistical analysis in genetic case-control studies,” Nature Protocols, vol. 6, no. 2, pp. 121–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. J. A. Morris and M. J. Gardner, “Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates,” British Medical Journal, vol. 296, no. 6632, pp. 1313–1316, 1988. View at Publisher · View at Google Scholar · View at Scopus
  43. A. J. Morales, R. H. Haubricht, J. Y. Hwang, H. Asakura, and S. S. C. Yen, “The effect of six months treatment with a 100 mg Daily Dose of Dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women,” Clinical Endocrinology, vol. 49, no. 4, pp. 421–432, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Dabbs Jr., “Salivary testosterone measurements: reliability across hours, days, and weeks,” Physiology and Behavior, vol. 48, no. 1, pp. 83–86, 1990. View at Publisher · View at Google Scholar · View at Scopus
  45. M. M. Kushnir, T. Blamires, A. L. Rockwood et al., “Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals,” Clinical Chemistry, vol. 56, no. 7, pp. 1138–1147, 2010. View at Publisher · View at Google Scholar
  46. R. L. Rosenfield and P. Otto, “Androstenediol levels in human peripheral plasma,” The Journal of Clinical Endocrinology and Metabolism, vol. 35, no. 6, pp. 818–822, 1972. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Lagergren, W. E. Ek, D. Levine et al., “Polymorphisms in genes of relevance for oestrogen and oxytocin pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma: a pooled analysis from the BEACON consortium,” PLoS ONE, vol. 10, no. 9, Article ID 0138738, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. IWDB, The Irish Wolfhound Database, 2016.
  49. D. J. Hunter, P. Kraft, K. B. Jacobs et al., “A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer,” Nature Genetics, vol. 39, no. 7, pp. 870–874, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. L. J. Scott, K. L. Mohlke, L. L. Bonnycastle et al., “A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants,” Science, vol. 316, no. 5829, pp. 1341–1345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Litchfield, R. Sultana, A. Renwick et al., “Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25,” Human Molecular Genetics, vol. 24, no. 4, pp. 1169–1176, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. I. Cleynen, G. Boucher, L. Jostins et al., “Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: A Genetic Association Study,” The Lancet, vol. 387, no. 10014, pp. 156–167, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. D. W. Belsky, T. E. Moffitt, K. Sugden et al., “Development and evaluation of a genetic risk score for obesity,” Biodemography and Social Biology, vol. 59, no. 1, pp. 85–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Ripatti, E. Tikkanen, M. Orho-Melander et al., “A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses,” The Lancet, vol. 376, no. 9750, pp. 1393–1400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. C. A. Ibrahim-Verbaas, M. Fornage, J. C. Bis et al., “Predicting stroke through genetic risk functions: the CHARGE risk score project,” Stroke, vol. 45, no. 2, pp. 403–412, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Ye, E. Austin, D. J. Schaid, and I. J. Kullo, “A multi-locus genetic risk score for abdominal aortic aneurysm,” Atherosclerosis, vol. 246, pp. 274–279, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Palmer and D. H. Maurice, “Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues,” Molecular Pharmacology, vol. 58, no. 2, pp. 247–252, 2000. View at Google Scholar · View at Scopus
  58. Y. W. Chung, C. Lagranha, Y. Chen et al., “Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 17, pp. E2253–E2262, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Wang, S. Bingaman, and V. H. Huxley, “Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 4, pp. H1146–H1154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Guo, Y. Du, S. Chang, K. Zhang, and J. Wang, “RSNPBase: a database for curated regulatory SNPs,” Nucleic Acids Research, vol. 42, no. 1, pp. D1033–D1039, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. M. A. Schaub, A. P. Boyle, A. Kundaje, S. Batzoglou, and M. Snyder, “Linking disease associations with regulatory information in the human genome,” Genome Research, vol. 22, no. 9, pp. 1748–1759, 2012. View at Publisher · View at Google Scholar · View at Scopus